Drug Repurposing Market
Drug repurposing, also known as drug re-profiling or drug re-positioning, refers to research regarding a biologic agent or a compound that can effectively treat one condition to see whether it can safely and effectively treat other health conditions or diseases. Solutions in the global drug repurposing market are beneficial for the manufacturers and producers in the healthcare and pharmaceutical industries as the process of new drug discovery is long and requires immense amount of time, testing, funding, and research efforts. Solutions offered in the global drug repurposing market allow pharmaceutical companies to test a drug intended to treat a certain condition and see whether that drug can be repurposed to treat another condition. This can save a huge amount of time and money for pharmaceutical manufacturers and researchers.
Advancements in the field of computational biology and computational technologies have triggered the development of the global drug repurposing market. On the other hand, lack of funding along with limited access to chemical structure data pertaining to various drug molecules can restrict the progress of the global drug repurposing market in coming years. Solutions offered by the players in global drug repurposing market are based on poly pharmacology. They are utilized to find treatment avenues for complex diseases that can include various types of cancer as well as a host of neurodegenerative diseases.
Global Drug Repurposing Market: Overview
National Institute of Health (NIH), of the US Department of Health offers the drug repurposing and gaining new approvals along with widening usage of the drug repurposing. It has numerous potential opportunities for growth by catering the unmet medical needs with some cost-effective solutions as alternative to the expensive drugs.
The global drug repurposing market report from Transparency market research offers the insights on the market dynamics. The report briefs the factors such as drivers, opportunities, trends, and restrains. The drug repurposing market report represents extensive outlook of the key players such as Porter’s five forces and SWOT analysis. Also, it provides the information such as merger and acquisition (M&A), research & development (R&D), and investment and profit analysis of the key players dominating the drug repurposing market.
Global Drug Repurposing Market: Drivers and Restraints
Need of the low investment in terms of time and money is fuelling demand for the drug repurposing which is leading to increase number of pipeline products is propelling growth of the drug repurposing market. Additionally, some of the other factors propelling growth of the global drug repurposing market are low research cost and easy bioavailability is propelling its growth from past few years. Additionally, it is a bio-based products which lowers the possibility of side effects and enhances the potential to reposition. This factor is propelling growth of the global drug repurposing market. However, lack of funding and limited information is restraining growth of the global drug repurposing market.
Global Drug Repurposing Market: Geographical Analysis
Based on geography, the market has been segmented into the following regions: North America, Europe, Latin America, Asia Pacific, Latin America and the Middle East and Africa. Of these, North America is expected to dominate the drug repurposing market. This growth is attributable to the high rates of expenses on research and treatments.
Global Drug Repurposing Market: Companies Mentioned
Some of the key players operating in the global drug repurposing market are Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan, and NuMedii.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.